BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30019001)

  • 1. Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012.
    Moore MS; Bocour A; Tran OC; Qiao B; Schymura MJ; Laraque F; Winters A
    Open Forum Infect Dis; 2018 Jul; 5(7):ofy144. PubMed ID: 30019001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma and Viral Hepatitis in New York City.
    Moore MS; Ivanina E; Bornschlegel K; Qiao B; Schymura MJ; Laraque F
    Clin Infect Dis; 2016 Dec; 63(12):1577-1583. PubMed ID: 27585801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
    Lui GC; Hui VW; Sze SF; Wong BC; Cheung C; Lee MP; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Hui YT; Wong GL
    Aliment Pharmacol Ther; 2023 Oct; 58(8):814-823. PubMed ID: 37515399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
    Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
    JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
    Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
    BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
    Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
    Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
    Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
    JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
    J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients.
    Merchante N; Rodríguez-Fernández M; Figueruela B; Rodríguez-Arrondo F; Revollo B; Ibarra S; Téllez F; Merino E; Montero-Alonso M; Galindo MJ; Rivero-Juárez A; Santos IL; Delgado-Fernández M; García-Deltoro M; Vera-Méndez FJ; García MA; Aguirrebengoa K; Portu J; Ríos-Villegas MJ; Villalobos M; Alemán-Valls MR; Mínguez C; Galera C; Macías J; Pineda JA;
    AIDS; 2020 Aug; 34(10):1497-1507. PubMed ID: 32675563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
    Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
    Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
    Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
    Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
    BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.